MDMB-FUBINACA (aka MDMB(N)-Bz-F), chemical name Methyl (S)-2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, is a fluoridated indazole-3-carboxamide synthetic compound (Fig. 1) which is considered a designer drug or a new psychoactive substance (NPS). Regarding the pharmacological effect of this compound, it might be referred as a synthetic cannabinoid (SCB) or cannabimimetic drug. Even though MDMB-FUBINACA is available worldwide via the Internet and the abuse of the drug seems to be increasing [1] there is little to no scientific/medical data concerning the pharmacology, pharmacokinetics, biotransformation or toxicology of the drug.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2if1V4N
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jCvX3K via IFTTT
-
Abstract Purpose of Review Our goal is to summarize the airway disease literature since September 11, 2001 (9/11), focusing on studies pub...
-
Treatment effectiveness holds considerable importance in the association between service quality and satisfaction in medical service studies...
-
Vol.25 No.2 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1P7bHxT via IFTTT
-
Publication date: Available online 16 January 2017 Source: International Journal of Pediatric Otorhinolaryngology Author(s): Kaveh Karimn...
-
Understanding Head And Neck Cancers - The Southeast Sun ... The Southeast Sun (NAPSI)—According to the Centers for Disease Control an...
-
Abstract Background Henoch–Schönlein purpura is the most common vasculitis in children. Its long-term prognosis depends on renal involve...
-
Publication date: 21 February 2017 Source: Cell Reports, Volume 18, Issue 8 Author(s): Arielle Glatman Zaretsky, Christoph Konradt, Fabien...
-
Publication date: September 2017 Source: International Journal of Biological Macromolecules, Volume 102 Author(s): Mohamed Esmat, Ahmed A...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου